Statistics
Publications
12
Citations
837
H-Index
11
Active since
2011
Salaheldin S. Hamed is an author at United States Food and Drug Administration specializing in pharmacology, medicine, and oncology.
Publications per year
2011–2024
12
12
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease–Associated Tumors
Jaleh Fallah, Michael H. Brave, Chana Weinstock et al. · Clinical Cancer Research · 2022 · 171 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 12